GLP-1 Weight Management, At-Home Diagnostics & Clinical Care
Clinician-supported GLP-1 care — so the spend produces outcomes instead of just producing spend.
GLP-1s are the fastest-rising line in nearly every pharmacy budget, and most employers are choosing between two bad options: cover them with no clinical structure and watch the trend compound, or exclude them and take the hit on recruiting, retention, and the comorbidities the drugs would have prevented. The uncomfortable middle fact is that a large share of people who start a GLP-1 stop within a year — so a meaningful portion of that spend buys neither sustained weight loss nor sustained anything.
Self-funded healthcare employers watching GLP-1 trend outrun the rest of the pharmacy budget, and any organization deciding whether to cover, exclude, or manage.
Is this the right fit?
The H.E.R.O. Snapshot tells us both. It is no-cost and takes about fifteen minutes.